GW Pharmaceuticals (GWPH)
125.24
-0.82 -0.65%
NASDAQ
Sep 27, 09:51
Delayed 2m
USD
View All Key Stats
GWPH Key Stats
| Income Statement | |
| Revenue (TTM) | 21.37M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -4.004 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -87.45M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 69.47% |
| Profit Margin (Quarterly) | -524.5% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 2.726B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 127.96 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 9.849 |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.00 |
| Free Cash Flow (Quarterly) | -18.34M |
| Return on Equity (TTM) | -25.74% |
View All GWPH News
GWPH News
-
WireHeadlineTime (ET)
-
PR Newswire09/27 09:31
-
PR Newswire09/27 09:11
-
PR Newswire09/27 09:01
-
Yahoo09/26 20:10
-
Yahoo09/26 19:20
-
Yahoo09/26 18:15
-
Yahoo09/26 18:03
-
Yahoo09/26 16:28
-
MT Newswires09/26 16:25
-
Yahoo09/26 13:23
View All Events
GWPH Events
| Date | Type | Description |
|---|---|---|
| 08/09/2016 08:30 EDT | Misc | GW Pharmaceuticals PLC Third Quarter Earnings Conference Call in 2016 |
| 08/09/2016 | Earnings | GW Pharmaceuticals PLC Third Quarter Earnings in 2016 Release |
| 05/05/2016 09:00 EDT | Misc | GW Pharmaceuticals PLC Second Quarter Earnings Conference Call in 2016 |
| 05/05/2016 | Earnings | GW Pharmaceuticals PLC Second Quarter Earnings in 2016 Release |
| 03/23/2016 | Misc | GW Pharmaceuticals Annual General Meeting |
| 02/10/2016 | Earnings | GW Pharmaceuticals PLC First Quarter Earnings Results in 2016 |
| 02/10/2016 | Misc | GW Pharmaceuticals PLC First Quarter Earnings Conference Call in 2016 |
| 12/07/2015 | Misc | GW Pharmaceuticals PLC Fourth Quarter Earnings Conference Call in 2015 |
| 12/07/2015 | Earnings | GW Pharmaceuticals PLC Fourth Quarter Earnings in 2015 Release |
| 12/07/2015 | Misc | GW Pharmaceuticals PLC 2015 Annual Report |
GWPH Fundamentals
Income Statement View Statement
GWPH Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.gwpharm.com
- Investor Relations URL: http://ir.gwpharm.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Next Earnings Release: N/A
- Last Earnings Release: August 09, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant.
GWPH Comparables
EditGWPH Excel Add-In Codes
- Name: =YCI("GWPH","name")
- Description: =YCI("GWPH","description")
- Sector: =YCI("GWPH","sector")
- Industry: =YCI("GWPH","industry")
- Est. Current Fiscal Year End: =YCI("GWPH","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other GWPH Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GWPH Tweets Stocktwits
Advertisement